Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma

As one of the most common malignant tumors worldwide, hepatocellular carcinoma (HCC) is known for its poor prognosis due to diagnosis only in advanced stages. Nearly 50% of the patients with the first diagnosis of HCC die within a year. Currently, the advancements in the integration of omics informa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaolin, Li, Jiahui, Gassa, Asmae, Buchner, Denise, Alakus, Hakan, Dong, Qiongzhu, Ren, Ning, Liu, Ming, Odenthal, Margarete, Stippel, Dirk, Bruns, Christiane, Zhao, Yue, Wahba, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097921/
https://www.ncbi.nlm.nih.gov/pubmed/32226301
http://dx.doi.org/10.7150/ijbs.44024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097921/
https://www.ncbi.nlm.nih.gov/pubmed/32226301
http://dx.doi.org/10.7150/ijbs.44024

Ejemplares similares